Matches in Wikidata for { <http://www.wikidata.org/entity/Q100422330> ?p ?o ?g. }
Showing items 1 to 50 of
50
with 100 items per page.
- Q100422330 description "artículu científicu espublizáu n'agostu de 2020" @default.
- Q100422330 description "bài báo khoa học" @default.
- Q100422330 description "scientific article published on 31 August 2020" @default.
- Q100422330 description "wetenschappelijk artikel" @default.
- Q100422330 description "наукова стаття, опублікована 31 серпня 2020" @default.
- Q100422330 name "Preparation and evaluation of soluble epoxide hydrolase inhibitors with improved physical properties and potencies for treating diabetic neuropathic pain" @default.
- Q100422330 name "Preparation and evaluation of soluble epoxide hydrolase inhibitors with improved physical properties and potencies for treating diabetic neuropathic pain" @default.
- Q100422330 type Item @default.
- Q100422330 label "Preparation and evaluation of soluble epoxide hydrolase inhibitors with improved physical properties and potencies for treating diabetic neuropathic pain" @default.
- Q100422330 label "Preparation and evaluation of soluble epoxide hydrolase inhibitors with improved physical properties and potencies for treating diabetic neuropathic pain" @default.
- Q100422330 prefLabel "Preparation and evaluation of soluble epoxide hydrolase inhibitors with improved physical properties and potencies for treating diabetic neuropathic pain" @default.
- Q100422330 prefLabel "Preparation and evaluation of soluble epoxide hydrolase inhibitors with improved physical properties and potencies for treating diabetic neuropathic pain" @default.
- Q100422330 P1433 Q100422330-FE35BAB4-0D7A-402E-B23B-DD9A797E3883 @default.
- Q100422330 P1476 Q100422330-E30F3AF2-B058-4455-BA41-526B53BDC191 @default.
- Q100422330 P2093 Q100422330-1B1ACF56-F130-491C-9F0B-B3604B5EB763 @default.
- Q100422330 P2093 Q100422330-21DB3CBD-238C-4D0D-85FC-AC019EE156D9 @default.
- Q100422330 P2093 Q100422330-41914E52-CBC0-4995-A394-70A8D29E8E9A @default.
- Q100422330 P2093 Q100422330-46E4BE4C-8FA0-4BE1-9799-A89154D6D40E @default.
- Q100422330 P2093 Q100422330-690D1BC8-FFE4-409F-976D-D8A1DF3904D8 @default.
- Q100422330 P2093 Q100422330-8A4E9FEA-0C0F-4F73-9D20-521A3F1F3DF1 @default.
- Q100422330 P2093 Q100422330-F5947685-CEBB-409A-97C8-73E2F759990C @default.
- Q100422330 P304 Q100422330-50E6B026-652F-40B8-992C-007852EA0D82 @default.
- Q100422330 P31 Q100422330-5B9F0DA4-6709-44FE-B2CE-E320C66026B9 @default.
- Q100422330 P356 Q100422330-F9C87C8E-889E-4825-B6ED-C73D94E4D0E2 @default.
- Q100422330 P433 Q100422330-6BD15B7A-AE3F-4BE8-9744-82A585AE5B02 @default.
- Q100422330 P478 Q100422330-9ABD1027-6504-44E2-850A-FAB38F14647E @default.
- Q100422330 P577 Q100422330-14E328E2-7682-44A4-A26E-A23BE86414DC @default.
- Q100422330 P698 Q100422330-C0984414-EBA2-4601-AF97-EAD7F6245CE0 @default.
- Q100422330 P921 Q100422330-27B4977D-765B-49DD-B98A-6013362D8032 @default.
- Q100422330 P932 Q100422330-62FB2878-8991-4F5C-BC60-C5CD8AA147A4 @default.
- Q100422330 P356 J.BMC.2020.115735 @default.
- Q100422330 P698 33007552 @default.
- Q100422330 P1433 Q2904200 @default.
- Q100422330 P1476 "Preparation and evaluation of soluble epoxide hydrolase inhibitors with improved physical properties and potencies for treating diabetic neuropathic pain" @default.
- Q100422330 P2093 "Bruce D Hammock" @default.
- Q100422330 P2093 "Christophe Morisseau" @default.
- Q100422330 P2093 "Jen C Ng" @default.
- Q100422330 P2093 "Jun Yang" @default.
- Q100422330 P2093 "Karen Wagner" @default.
- Q100422330 P2093 "Kin Sing Stephen Lee" @default.
- Q100422330 P2093 "Sung-Hee Hwang" @default.
- Q100422330 P304 "115735" @default.
- Q100422330 P31 Q13442814 @default.
- Q100422330 P356 "10.1016/J.BMC.2020.115735" @default.
- Q100422330 P433 "22" @default.
- Q100422330 P478 "28" @default.
- Q100422330 P577 "2020-08-31T00:00:00Z" @default.
- Q100422330 P698 "33007552" @default.
- Q100422330 P921 Q7558943 @default.
- Q100422330 P932 "7914304" @default.